A 340B Provider Audit by a Manufacturer Reaches Final Report Stage

by Admin | February 22, 2013 10:11 am

February 22, 2013—One of the four audits of 340B covered entities being conducted by drug manufacturers has reached the final report stage, the Health Resources and Services Administration (HRSA) said yesterday.

HRSA, responding to questions about a Federal Register notice yesterday[1] regarding 340B audits and dispute resolution, said it has received six audit work plans from manufacturers, only four of which have proceeded to audits. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. a Federal Register notice yesterday: http://www.gpo.gov/fdsys/pkg/FR-2013-02-21/pdf/2013-03912.pdf
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2013/02/a-340b-provider-audit-by-a-manufacturer-reaches-final-report-stage/

Copyright ©2026 340binformed.org unless otherwise noted.